https://www.yiliao.com/index.php?action=history&feed=atom&title=SUZ12
SUZ12 - 版本历史
2026-04-19T20:21:39Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=SUZ12&diff=314564&oldid=prev
223.160.136.36：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-15T08:31:08Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>[[SUZ12]]</strong>（<strong>[[Suppressor of zeste 12 protein homolog]]</strong>）是一种核心的[[表观遗传]]调节蛋白，是<strong>[[PRC2复合物]]</strong>（[[Polycomb Repressive Complex 2]]）不可或缺的结构组分。[[SUZ12]]作为复合物的“支架亚基”，不仅负责维持整个[[PRC2]]结构的完整性，还通过其[[VEFS结构域]]与催化亚基<strong>[[EZH2]]</strong>（或[[EZH1]]）直接结合，从而极大地增强其对[[组蛋白H3]]第27位赖氨酸（[[H3K27]]）的甲基转移酶活性。在[[临床肿瘤学]]中，[[SUZ12]]的突变或功能失调与<strong>[[恶性外周神经鞘瘤]]</strong>（[[MPNST]]）、[[髓系白血病]]及多种[[实体瘤]]的发生密切相关，是当前针对[[表观遗传]]脆弱点进行药物开发的关键靶点。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 320px; float: right; margin: 0 0 25px 25px; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #ffffff 0%, #e0f2fe 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">[[SUZ12]]</div><br />
<div style="font-size: 0.75em; opacity: 0.85; margin-top: 4px;">PRC2核心支架蛋白 · 点击展开</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 20px; text-align: center; background-color: #f8fafc;"><br />
<div style="padding: 12px; border: 1px solid #e2e8f0; border-radius: 8px; background: #fff; display: inline-block;"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px; text-align: center;">[[PRC2]]复合物整体结构示意图</div><br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">染色体位置：17q11.2</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 45%;">[[Entrez]]ID</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">23512</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[HGNC]]ID</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">17101</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[UniProt]]</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">Q15022</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">关键结构域</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">[[VEFS]] / [[锌指]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[分子量]]</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">约83.1kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569;">功能伙伴</th><br />
<td style="padding: 12px; color: #0f172a;">[[EZH2]]•[[EED]]•[[RBBP4]]</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：PRC2复合物的装配核心</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
[[SUZ12]]通过其多结构域特征，在[[染色质]]重塑过程中发挥多重协调作用：<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>稳定复合物支架：</strong>[[SUZ12]]构成了[[PRC2]]的核心骨架。没有[[SUZ12]]，催化亚基[[EZH2]]将无法与调节亚基[[EED]]稳定结合，导致复合物降解及[[H3K27me3]]标记丢失。</li><br />
<li style="margin-bottom: 12px;"><strong>变体招募介导：</strong>[[SUZ12]]能够与不同的[[辅助因子]]（如[[PCL1-3]]、[[AEBP2]]等）结合，分别形成<strong>[[PRC2.1]]</strong>和<strong>[[PRC2.2]]</strong>复合物，从而精准决定复合物在[[基因组]]上的定位。</li><br />
<li style="margin-bottom: 12px;"><strong>变构激活调节：</strong>[[SUZ12]]的[[VEFS结构域]]不仅结合[[EZH2]]，还参与感知[[EED]]传递的变构信号，从而调控甲基转移酶的整体活性。</li><br />
<li style="margin-bottom: 12px;"><strong>染色质特异性结合：</strong>其[[锌指结构域]]可能参与识别特定的[[DNA]]序列或[[组蛋白]]修饰状态，确保基因沉默的特异性。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">临床意义与病理学关联</h2><br />
<br />
<div style="overflow-x: auto; margin: 25px auto; width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">病理领域</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #475569;">SUZ12 异常类型</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #1e40af;">临床表型与意义</th><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[恶性外周神经鞘瘤]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">双等位基因缺失/失活突变</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">导致全基因组[[H3K27me3]]消失，是诊断[[MPNST]]的金标准标志物。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[子宫内膜间质肉瘤]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[JAZF1-SUZ12]] 基因融合</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">产生异常嵌合蛋白，导致[[PRC2]]功能紊乱并诱发恶性转化。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[髓系白血病]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">功能丧失型突变</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">与[[T-ALL]]及[[EET-ALL]]相关，导致造血分化受阻。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">诊疗策略：针对PRC2缺损与过表达的干预</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
基于[[SUZ12]]状态的精准干预正在改变[[表观遗传]]肿瘤的治疗格局：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>[[合成致死]]策略：</strong>在[[SUZ12]]缺失的肿瘤（如[[MPNST]]）中，肿瘤细胞对[[BRD4]]或[[HDAC]]抑制剂表现出极高的敏感性。临床正探索通过“二次打击”实现特异性杀伤。</li><br />
<li style="margin-bottom: 12px;"><strong>[[蛋白质降解]] (PROTAC)：</strong>针对[[SUZ12]]高表达的肿瘤，研发可同时降解[[SUZ12]]和[[EZH2]]的[[PROTAC]]药物，可比单一激酶抑制更彻底地瓦解[[PRC2]]复合物。</li><br />
<li style="margin-bottom: 12px;"><strong>[[伴随诊断]]价值：</strong>通过[[IHC]]检测[[H3K27me3]]的缺失，间接反映[[SUZ12]]的功能状态，已成为区分良恶性[[神经鞘瘤]]的关键手段。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">关键相关概念</h2><br />
<div style="background-color: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 15px; margin: 20px 0;"><br />
<ul style="margin: 0; padding-left: 20px; color: #334155;"><br />
<li style="margin-bottom: 8px;"><strong>[[PRC2]]：</strong>由[[EZH1/2]]、[[EED]]、[[SUZ12]]及[[RBBP4/7]]组成，负责基因组[[甲基化]]沉默。</li><br />
<li style="margin-bottom: 8px;"><strong>[[VEFS结构域]]：</strong>[[SUZ12]]特有的、与[[EZH2]]相互作用的核心功能域。</li><br />
<li style="margin-bottom: 8px;"><strong>[[H3K27me3]]：</strong>由[[PRC2]]产生的抑制性标记，是[[SUZ12]]正常功能的下游产物。</li><br />
<li style="margin-bottom: 8px;"><strong>[[瓦美妥司他]]：</strong>通过抑制[[PRC2]]催化活性，间接影响[[SUZ12]]参与的信号轴。</li><br />
</ul><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2.2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Pasini D, et al. (2004).</strong> <em>Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.</em> <strong>[[The EMBO Journal]]</strong>.[Academic Review]<br><br />
<span style="color: #475569;">[权威点评]：该项经典研究首次确立了SUZ12在维持PRC2稳定性及催化活性中的不可替代性。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>De Raedt T, et al. (2014/2025 update).</strong> <em>PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4 inhibition.</em> <strong>[[Nature]]</strong>.<br><br />
<span style="color: #475569;">[核心价值]：系统解析了SUZ12缺失在神经鞘瘤发病中的作用，并提出了合成致死的治疗新方向。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
[[SUZ12]] 染色质调控生态 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">关联亚基</td><br />
<td style="padding: 10px 15px; color: #334155;">[[EZH2]]•[[EED]]•[[RBBP4]]•[[AEBP2]]•[[PCL]]家族</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">关联病理</td><br />
<td style="padding: 10px 15px; color: #334155;">[[MPNST]]•[[子宫肉瘤]]•[[T-ALL]]•[[神经纤维瘤病]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">战略实体</td><br />
<td style="padding: 10px 15px; color: #334155;">[[Epizyme]]•[[Novartis]]•[[Daiichi Sankyo]]•[[Memorial Sloan Kettering]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">研究前沿</td><br />
<td style="padding: 10px 15px; color: #334155;">[[针对SUZ12融合蛋白的精准治疗]]•[[基于PRC2结构的功能偏向性抑制剂]]•[[SUZ12在生殖细胞分化中的作用]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
223.160.136.36